Provided by Tiger Trade Technology Pte. Ltd.

Maze Therapeutics

29.60
+0.17000.58%
Post-market: 29.600.00000.00%19:30 EDT
Volume:282.29K
Turnover:8.31M
Market Cap:1.64B
PE:-11.76
High:29.76
Open:29.27
Low:28.33
Close:29.43
52wk High:53.65
52wk Low:12.91
Shares:55.25M
Float Shares:37.25M
Volume Ratio:0.76
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5172
EPS(LYR):-3.0510
ROE:-37.35%
ROA:-21.79%
PB:3.61
PE(LYR):-9.70

Loading ...

Aug 17, 2026

Major Issues Report

Form 8-K - Current report
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 11, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2026

Major Issues Report

Form 8-K - Current report
Aug 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 10, 2026

Major Issues Report

Form 8-K - Current report
Jun 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2026

Major Issues Report

Form 8-K - Current report
Apr 22, 2026

Major Issues Report

Form 8-K - Current report
Apr 01, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Mar 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 25, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]